We are live on
!
Find out more
AAM
Ascension Asset Management Portfolio holdings
AUM
$191M
This Fund
S&P 500
This Quarter
Est. Return
+7.38%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$110M
AUM Growth
–
Cap. Flow
+$107M
Cap. Flow
% of AUM
97.31%
Top 10 Holdings %
Top 10 Hldgs %
28.63%
Holding
74
New
74
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$5.51M |
| 2 |
Apple
AAPL
|
+$3.33M |
| 3 |
RTN
Raytheon Company
RTN
|
+$3.02M |
| 4 |
Lockheed Martin
LMT
|
+$3.01M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$2.87M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 27.55% |
| 2 | Technology | 21.36% |
| 3 | Healthcare | 15.18% |
| 4 | Consumer Staples | 10.05% |
| 5 | Financials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Alphabet (Google) Class C
GOOG
$4.08T
| $1.12M | 1.02% |
+21,480
| New | +$1.09M |
|
52
Coca-Cola
KO
$381B
| $961K | 0.88% |
+20,950
| New | +$963K |
|
53
GE Aerospace
GE
$368B
| $881K | 0.8% |
+10,537
| New | +$1.01M |
|
54
Clorox
CLX
$11.7B
| $853K | 0.78% |
+5,735
| New | +$780K |
|
55
NVIDIA
NVDA
$4.72T
| $805K | 0.73% |
+166,400
| New | +$827K |
|
56
Abbott
ABT
$183B
| $779K | 0.71% |
+13,644
| New | +$756K |
|
57
Novartis
NVS
$301B
| $746K | 0.68% |
+9,916
| New | +$748K |
|
58
SLB Ltd
SLB
$72.6B
| $718K | 0.65% |
+10,657
| New | +$691K |
|
59
Corning
GLW
$116B
| $688K | 0.63% |
+21,517
| New | +$677K |
|
|
FITB
60
Fifth Third Bancorp
FITB
$51.3B
| $671K | 0.61% |
+22,116
| New | +$645K |
|
61
Merck
MRK
$321B
| $644K | 0.59% |
+11,995
| New | +$665K |
|
62
Baxter International
BAX
$13.8B
| $637K | 0.58% |
+9,850
| New | +$633K |
|
63
JPMorgan Chase
JPM
$933B
| $604K | 0.55% |
+5,648
| New | +$572K |
|
64
IBM
IBM
$209B
| $552K | 0.5% |
+3,766
| New | +$548K |
|
65
Edwards Lifesciences
EW
$50B
| $496K | 0.45% |
+13,200
| New | +$484K |
|
66
Cigna
CI
$76.1B
| $473K | 0.43% |
+2,330
| New | +$464K |
|
67
Pfizer
PFE
$142B
| $458K | 0.42% |
+13,316
| New | +$454K |
|
68
McDonald's
MCD
$191B
| $456K | 0.42% |
+2,650
| New | +$445K |
|
69
WEC Energy
WEC
$35.8B
| $399K | 0.36% |
+6,000
| New | +$403K |
|
|
CDK
70
DELISTED
CDK Global, Inc.
CDK
| $344K | 0.31% |
+4,826
| New | +$324K |
|
71
KeyCorp
KEY
$24.2B
| $321K | 0.29% |
+15,904
| New | +$300K |
|
72
Chevron
CVX
$383B
| $288K | 0.26% |
+2,298
| New | +$272K |
|
73
Southern Company
SO
$106B
| $267K | 0.24% |
+5,558
| New | +$283K |
|
74
Dell
DELL
$262B
| $237K | 0.22% |
+10,376
| New | +$235K |
|
Similar funds
SWM
HWMA
WWP
1C
GA
CBC
IGWM
RA
Ascension Asset Management's Q4 2017 Portfolio in Review
Q4 2017 is the first quarter with a 13F filing on record for Ascension Asset Management, which disclosed 74 positions worth $110M. Its ten largest holdings account for 29% of the portfolio.
Its largest position is Johnson & Johnson: 39,543 shares worth $5.53M.
By sector, the portfolio is most concentrated in Industrials at 28% of assets, followed by Technology and Healthcare.
- Ascension Asset Management's largest Q4 2017 buy was Johnson & Johnson: 39,543 shares worth $5.53M.
- Ascension Asset Management's ten largest holdings make up 29% of its $110M portfolio in Q4 2017.
- Ascension Asset Management disclosed 74 positions in Q4 2017, its first 13F filing on record.
Based on Ascension Asset Management's 13F filing for Q4 2017, filed 24 Jan 2018.